SEC charges stockbroker and friend with insider trading
The Securities and Exchange Commission (SEC) has charged a stockbroker and his friend with participating in an insider trading scheme to profit in advance of two major announcements out of a pharmaceutical company. The SEC alleges that Paul T. Rampoldi coordinated the insider trading with two other brokers at his firm as well as a then-IT executive…
Read more